Literature DB >> 16303926

Correlation of clinical and genetic findings in Hungarian patients with Stargardt disease.

Janos Hargitai1, Jana Zernant, Gabor M Somfai, Rita Vamos, Agnes Farkas, Gyorgy Salacz, Rando Allikmets.   

Abstract

PURPOSE: Autosomal recessive Stargardt disease (arSTGD) presents with substantial clinical and genetic heterogeneity. This study was conducted to correlate foveolar thickness (FT) and total macular volume (TMV), measured by optical coherence tomography (OCT), with other clinical characteristics and with specific genetic variation in Hungarian patients with arSTGD.
METHODS: After a standard ophthalmic workup, both eyes of 35 patients with STGD from Hungary and of 25 age-matched healthy control subjects were tested with OCT. FT and TMV were measured automatically with the OCT mapping software in the nine Early Treatment Diabetic Retinopathy Study areas of 3500 microm in diameter. All patients were screened for mutations by a combination of the ABCR400 microarray and direct sequencing.
RESULTS: The patients with STGD presented with markedly thinned retina in the foveola and decreased macular volume, 72 microm and 1.69 mm3, respectively, compared with 169 microm and 2.48 mm3 in the normal subjects, respectively. Statistically significant correlation was observed between visual acuity (VA) and TMV and between VA and FT. Disease-associated mutations were detected in 23 (65.7%) of 35 patients, including 48.5% with both alleles and 17.2% with one allele. The most frequent ABCA4 alleles in Hungarian patients with STGD were L541P/A1038V (in 28% of all patients), G1961E (20%) and IVS40+5G-->A (17%). Specific genotypes correlated with some phenotypic features and allowed for predictions of the disease progression.
CONCLUSIONS: Hungarian patients with STGD presented with extensive foveolar thinning and macular volume loss. Genetic analysis detected several ABCA4 alleles at high frequency in the cohort of patients, suggesting founder effect(s). Unusually homogeneous distribution of disease-associated mutations aided genotype-phenotype correlation analyses in this population.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16303926     DOI: 10.1167/iovs.05-0504

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  16 in total

1.  Retinal phenotypes in patients homozygous for the G1961E mutation in the ABCA4 gene.

Authors:  Tomas R Burke; Gerald A Fishman; Jana Zernant; Carl Schubert; Stephen H Tsang; R Theodore Smith; Radha Ayyagari; Robert K Koenekoop; Allison Umfress; Maria Laura Ciccarelli; Alfonso Baldi; Alessandro Iannaccone; Frans P M Cremers; Caroline C W Klaver; Rando Allikmets
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-07-03       Impact factor: 4.799

Review 2.  Allelic and phenotypic heterogeneity in ABCA4 mutations.

Authors:  Tomas R Burke; Stephen H Tsang
Journal:  Ophthalmic Genet       Date:  2011-04-21       Impact factor: 1.803

3.  G1961E mutant allele in the Stargardt disease gene ABCA4 causes bull's eye maculopathy.

Authors:  Wener Cella; Vivienne C Greenstein; Jana Zernant-Rajang; Theodore R Smith; Gaetano Barile; Rando Allikmets; Stephen H Tsang
Journal:  Exp Eye Res       Date:  2009-02-13       Impact factor: 3.467

4.  Comparison of retinal thickness by Fourier-domain optical coherence tomography and OCT retinal image analysis software segmentation analysis derived from Stratus optical coherence tomography images.

Authors:  Erika Tátrai; Sudarshan Ranganathan; Mária Ferencz; Delia Cabrera DeBuc; Gábor Márk Somfai
Journal:  J Biomed Opt       Date:  2011-05       Impact factor: 3.170

5.  Treatment of Stargardt disease with dobesilate.

Authors:  Pedro Cuevas; Luis A Outeiriño; Javier Angulo; Guillermo Giménez-Gallego
Journal:  BMJ Case Rep       Date:  2012-10-12

6.  Loss of peripapillary sparing in non-group I Stargardt disease.

Authors:  Tomas R Burke; Rando Allikmets; R Theodore Smith; Peter Gouras; Stephen H Tsang
Journal:  Exp Eye Res       Date:  2010-08-07       Impact factor: 3.467

7.  DHA supplementation for late onset Stargardt disease: NAT-3 study.

Authors:  Giuseppe Querques; Pascale Benlian; Bernard Chanu; Nicolas Leveziel; Gabriel Coscas; Gisele Soubrane; Eric H Souied
Journal:  Clin Ophthalmol       Date:  2010-07-21

8.  Evaluation of macular abnormalities in Stargardt's disease using optical coherence tomography and scanning laser ophthalmoscope microperimetry.

Authors:  Fatmire Berisha; Gilbert T Feke; Shakhsanam Aliyeva; Koji Hirai; Norbert Pfeiffer; Tatsuo Hirose
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-10-22       Impact factor: 3.117

9.  Molecular diagnosis of putative Stargardt Disease probands by exome sequencing.

Authors:  Samuel P Strom; Yong-Qing Gao; Ariadna Martinez; Carolina Ortube; Zugen Chen; Stanley F Nelson; Steven Nusinowitz; Deborah B Farber; Michael B Gorin
Journal:  BMC Med Genet       Date:  2012-08-03       Impact factor: 2.103

10.  Reduced macular function in ABCA4 carriers.

Authors:  Ulrika Kjellström
Journal:  Mol Vis       Date:  2015-07-17       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.